Flynn James E 13D and 13G filings for Orchard Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 10:07 am Sale |
2022-12-31 | 13G | Orchard Therapeutics plc ORTX |
Flynn James E | 316,171 2.500% |
-378,771 (-54.50%) |
Filing |
| 2022-02-11 4:12 pm Unchanged |
2021-12-31 | 13G | Orchard Therapeutics plc ORTX |
Flynn James E | 694,942 5.540% |
0 (Unchanged) |
Filing |
| 2021-02-12 12:30 pm Sale |
2020-12-31 | 13G | Orchard Therapeutics plc ORTX |
Flynn James E | 694,942 7.110% |
-191,283 (-21.58%) |
Filing |